07:00 , May 28, 2012 |  BC Week In Review  |  Company News

Everist Genomics, Manipal deal

Everist and Manipal formed a JV to market Everist's AngioDefender and CardioDefender diagnostics for cardiovascular disease in India, as well as Everist's gene-based molecular assays to predict cancer recurrence. Everist said it expects the JV...
08:00 , Nov 7, 2011 |  BC Week In Review  |  Company News

Angiologix Inc., Everist Genomics deal

Everist acquired Angiologix for an undisclosed sum. Angiologix is developing AngioDefender to aid in diagnosing cardiovascular disease by measuring changes in volume of a segment of the brachial artery in response to a temporary occlusion...